DK0950113T3 - Detektion af genetisk prædisposition for synstruende diabetisk retinopati - Google Patents

Detektion af genetisk prædisposition for synstruende diabetisk retinopati

Info

Publication number
DK0950113T3
DK0950113T3 DK97944986T DK97944986T DK0950113T3 DK 0950113 T3 DK0950113 T3 DK 0950113T3 DK 97944986 T DK97944986 T DK 97944986T DK 97944986 T DK97944986 T DK 97944986T DK 0950113 T3 DK0950113 T3 DK 0950113T3
Authority
DK
Denmark
Prior art keywords
diabetic retinopathy
vision
detection
genetic predisposition
identified
Prior art date
Application number
DK97944986T
Other languages
English (en)
Inventor
Gordon Duff
Ian Rennie
Robert Richardson
Original Assignee
Interleukin Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interleukin Genetics Inc filed Critical Interleukin Genetics Inc
Application granted granted Critical
Publication of DK0950113T3 publication Critical patent/DK0950113T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Eye Examination Apparatus (AREA)
  • Catching Or Destruction (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97944986T 1996-10-10 1997-10-09 Detektion af genetisk prædisposition for synstruende diabetisk retinopati DK0950113T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9621129.7A GB9621129D0 (en) 1996-10-10 1996-10-10 Detecting genetic predisposition to sight-threatening diabetic retinopathy
PCT/GB1997/002790 WO1998015653A1 (en) 1996-10-10 1997-10-09 Detecting genetic predisposition to sight-threatening diabetic retinopathy

Publications (1)

Publication Number Publication Date
DK0950113T3 true DK0950113T3 (da) 2003-01-27

Family

ID=10801212

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97944986T DK0950113T3 (da) 1996-10-10 1997-10-09 Detektion af genetisk prædisposition for synstruende diabetisk retinopati

Country Status (12)

Country Link
US (1) US6713253B1 (da)
EP (1) EP0950113B1 (da)
AT (1) ATE224456T1 (da)
AU (1) AU742957B2 (da)
CA (1) CA2267155C (da)
DE (1) DE69715669T2 (da)
DK (1) DK0950113T3 (da)
ES (1) ES2186926T3 (da)
GB (1) GB9621129D0 (da)
IL (1) IL129390A (da)
WO (1) WO1998015653A1 (da)
ZA (1) ZA979071B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524795B1 (en) 1997-03-10 2003-02-25 Interleukin Genetics, Inc. Diagnostics for cardiovascular disorders
US6720141B1 (en) * 1999-11-01 2004-04-13 Interleukin Genetics, Inc. Diagnostics and therapeutics for restenosis
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease
US20050032077A1 (en) * 1998-03-10 2005-02-10 Duff Gordon W. Detecting genetic predisposition to sight-threatening diabetic retinopathy
US6733967B1 (en) 1998-04-21 2004-05-11 Interleukin Genetics, Inc. Fetal testing for prediction of low birth weight
AU769949B2 (en) * 1998-04-21 2004-02-12 Interleukin Genetics, Inc. Fetal testing for prediction of low birth weight
US6251598B1 (en) 1998-10-30 2001-06-26 Interleukin Genetics, Inc. Methods for diagnosing sepsis
US20090023147A1 (en) * 1999-08-30 2009-01-22 Kenneth Kornman Diagnostics and therapeutics for osteoporosis
EP1252895A4 (en) * 2000-01-31 2003-04-16 Santen Pharmaceutical Co Ltd REMEDIES FOR OPHTHALMIC DISORDERS
GB0009294D0 (en) * 2000-04-15 2000-05-31 Sec Dep For The Home Departmen Improvements in and relating to analysis of DNA samples
WO2003044176A2 (en) * 2001-11-19 2003-05-30 Interleukin Genetics, Inc. Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases
WO2003064600A2 (en) 2002-01-25 2003-08-07 Interleukin Genetics, Inc. The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes
CA2501095A1 (en) * 2002-10-15 2004-04-29 Novartis Ag Methods to predict edema as a side effect of drug treatment
CA2534365A1 (en) * 2003-08-08 2005-02-17 Interleukin Genetics, Inc. Diagnostic and therapeutics for osteoporosis
GB0417763D0 (en) * 2004-07-09 2004-09-08 Sec Dep For The Home Departmen Improvements in and relating to the investigation of dna samples
US8105775B2 (en) 2005-10-25 2012-01-31 Interleukin Genetics, Inc. IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes
EP2005194A4 (en) * 2006-03-24 2009-05-27 Univ Louisville Res Found HEMOGLOBIN-BASED METHODS FOR PROPHYLAXIS, DIAGNOSTIC OR BZW. TREATMENT OF NETWORK DISEASES
WO2007113490A1 (en) * 2006-04-03 2007-10-11 Forensic Science Service Limited Improvements in and relating to analysis of mixed source dna profiles
WO2009015087A2 (en) * 2007-07-20 2009-01-29 Potentia Pharmaceuticals, Inc. Compositions and methods for treatment of trauma
ES2337115B2 (es) * 2007-09-26 2011-01-24 Universidade De Santiago De Compostela Metodo para la deteccion del riesgo de desarrollar vitreorretinopatiaproliferante (vrp).
US20090170105A1 (en) * 2007-11-08 2009-07-02 Interleukin Genetics, Inc. Diagnostics for Aging-Related Dermatologic Disorders
JP5762282B2 (ja) * 2008-05-02 2015-08-12 インタールーキン ジェネティクス, インコーポレイテッド 変形性関節症に関連する状態に対する遺伝的素因の検出
EP2304052A2 (en) * 2008-05-02 2011-04-06 Interleukin Genetics, Inc. Detecting genetic predisposition to osteoarthritis associated conditions
WO2017123696A1 (en) 2016-01-12 2017-07-20 Interleukin Genetics, Inc. Methods for predicting response to treatment
US10337070B2 (en) 2017-01-12 2019-07-02 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
US20220249660A1 (en) 2019-06-06 2022-08-11 Sitokine Limited Compositions and methods for treating lung, colorectal and breast cancer
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986007464A1 (en) 1985-06-14 1986-12-18 Genetic Systems Corporation Methods for identifying alleles associated with increased risk of diabetes
US5039606A (en) 1987-10-29 1991-08-13 Virginia Mason Research Center Diagnostic probe for diabetes type I predisposition
US5686246A (en) 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
US5698399A (en) 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis

Also Published As

Publication number Publication date
CA2267155C (en) 2003-07-08
AU742957B2 (en) 2002-01-17
EP0950113B1 (en) 2002-09-18
ES2186926T3 (es) 2003-05-16
DE69715669D1 (de) 2002-10-24
US6713253B1 (en) 2004-03-30
AU4631197A (en) 1998-05-05
IL129390A0 (en) 2000-02-17
IL129390A (en) 2002-05-23
CA2267155A1 (en) 1998-04-16
ATE224456T1 (de) 2002-10-15
GB9621129D0 (en) 1996-11-27
ZA979071B (en) 1998-07-08
EP0950113A1 (en) 1999-10-20
DE69715669T2 (de) 2003-09-18
WO1998015653A1 (en) 1998-04-16

Similar Documents

Publication Publication Date Title
DK0950113T3 (da) Detektion af genetisk prædisposition for synstruende diabetisk retinopati
ATE429511T1 (de) Verfahren zur entwicklung von gensätzen zu diagnostischen und therapeutischen zwecken auf grundlage des expressions- und methylierungsstatus der gene
NO980439L (no) Detektering av genetisk predisposisjon for periodontal sykdom
DE69724209D1 (de) Erkennung einer genetischen prädisposition fur osteoporose
WO2001090419A3 (en) Methods for genetic analysis of dna to detect sequence variances
DE69029018D1 (de) Verfahren zum Nachweis von benachbarten und entfernt lokalisierten Allelen als Haplotypen mittels Intronsequenzanalyse
WO2002086163A8 (en) Methods for high throughput genome analysis using restriction site tagged microarrays
WO2000050872A3 (en) A system for cell-based screening
DK1131471T3 (da) Et system til cellebaseret screening
WO2001001218A3 (en) Methods for obtaining and using haplotype data
DE69704031D1 (de) Test zur diagnose eines erhöhten brustkrebs-risikos
ATE361378T1 (de) Screeningverfahren auf anti-protease resistenz hiv-2-haltiger zellen, ausgehend von biologischen patientenproben
WO2001004349A3 (en) Method for the diagnosis or the prognosis of alzheimer disease therapeutical composition for preventing or treating alzheimer disease
ATE419380T1 (de) Bestimmung des kollagen genotyps
DE69710469D1 (de) Diagnoseverfahren und vorrichtung zum nachweis der prädisposition zu bestimmten krankheitszuständen, insbesondere osteoporose, auf basis von il-6 genpolymorphismus
Xu et al. Two multiplex PCR-based DNA assays for the thrombosis risk factors prothrombin G20210A and coagulation factor V G1691A polymorphisms
WO2005049866A3 (en) Methods of detecting charcot-marie tooth disease type 2a
WO2002053018A3 (en) Method of detecting polymorphisms associated with breast carcinoma in mhc genes
DE60230988D1 (de) Proteine in der diabetes-proteomanalyse
WO2001077380A3 (en) Method for predicting predisposition to a disease associated with mutations in a rpgr gene
WO2002020835A3 (en) Genetic study
WO2002090585A3 (en) Genetic polymorphism pattern of tgfb1 as marker for susceptability to renal disease
WO2005058931A3 (en) Methods and algorithms for identifying genomic regulatory sites
RU2004123610A (ru) Способ обнаружения предрасположенности к кардиоваскулярному заболеванию
ATE442456T1 (de) Verfahren zur bestimmung von zirkulierender dns in plasma und zum nachweis von krebs